Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / OnabotulinumtoxinA for primary new daily persistent headache and comparison to chronic migraine.

< BACK TO ARCHIVE


Papers: 8 Feb 2025 - 14 Feb 2025


2025 Feb


Cephalalgia


39924901


45


2

OnabotulinumtoxinA for primary new daily persistent headache and comparison to chronic migraine.

Authors

Cheema S, Lagrata S, Rantell KR, Ahmed M, Kamourieh S, Matharu MS

Abstract

New daily persistent headache (NDPH) is an often treatment-refractory primary headache disorder with a lack of evidence base for treatment.
Read This Paper